WHO ICTRP trial

Retrospective Cohort Study on the Effects of Secukinumab versus Acitretin…

ChiCTR2500109183 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2500109183
Public title Retrospective Cohort Study on the Effects of Secukinumab versus Acitretin Capsules in Preventing the Progression of Moderate-to-Severe Plaque Psoriasis to Psoriatic Arthritis
Scientific title Retrospective Cohort Study on the Effects of Secukinumab versus Acitretin Capsules in Preventing the Progression of Moderate-to-Severe Plaque Psoriasis to Psoriatic Arthritis
Primary sponsor The First Affiliated Hospital of Army Medical University PLA
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Observational study
Phase 4
Countries China
Conditions Psoriasis and psoriatic arthritis
Interventions Observation group:NA
Registration date Sep 15, 2025
Target size Observation group:3191
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations